维普期刊资源整合服务平台（V6.5）

193篇 您的检索式：作者名="CorPechot C"

选中清除导出查看参考文献查看引证文献引用追踪共10页首页上一页第1页下一页末页 /10 跳转

	题名	作者	年代	出处	被引量
1	原发性胆汁性胆管炎肝移植术后预防性熊去氧胆酸治疗的长期疗效观察显示文摘【据Journal of Hepatology 2020年4月报道】题:原发性胆汁性胆管炎肝移植术后预防性熊去氧胆酸治疗的长期疗效观察(作者Corpechot C等)原发性胆汁性胆管炎(PBC)肝移植术后复发率高,这会损伤移植物和降低患者的生存。熊去氧胆酸(UDCA)是目前治疗PBC的标准药物,来自索邦大学圣安东尼研究中心的Corpechot等研究了预防性UDCA治疗对肝移植术后PBC复发的发生率和长期疗效的影响。	李晓珂季慧范 CORPECHOT C CHAZOUILLèRES O BELNOU P	2020	临床肝胆病杂志2020，36，10：	7
2	Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis显示文摘	Corpechot C Abenavoli L Rabahi N		Hepatology0，，：	3
3	Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis 显示文摘	Rosmorduc O Wendum D Corpechot C	1999	Am J Pathol1999，155，4：	2
4	Notch 3 mutations in CADASIL, a hereditary adultonset condition causing stroke and dementia 显示文摘	Joutel A Corpechot C Ducros A	1996	Nature1996，383，：	1
5	Primary biliary cirrhosis:incidence and predictive factors of cirrhosis development in ursodidol treated patients显示文摘	CORPECHOT C CARRAT F PUNPON R	2002	Gastroenterology2002，122，：	1
6	The detect of ursodeoxzycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis 显示文摘	CORPECHOT C CARRAT F BONNAND AM	2000	Hepatology2000，32，：	1
7	Smoking as an independent risk factor of liver fibrosis in primary biliary cirrhosis显示文摘	Corpechot C Gaouar F Chrrtien Y	2012	J Hepatol2012，56，1：	1
8	An effect of ur-sodeoxyeholieacid therapy on liver fibrosis progression in pri mary biliary eirrhosis显示文摘	Corpechot C Carrat F Bonnand A	2000	Hepatology2000，32，12：	1
9	Hypoxia-induced VEGF and collagen 1 expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis显示文摘	Corpechot C Barbu V Wendum D	2002	Hepatology2002，35，：	1
10	Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis显示文摘	Corpechot C Chr6tien Y Chazouillres O	2010	J Hepatol2010，53，：	1
11	Notch3 mutations in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL),a mendelian condition causing stroke and vascular dementia显示文摘	Joutel A Corpechot C Ducros A	1997	Ann N Y Acad Sci1997，826，1：	1
12	Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis显示文摘	Rosmorduc O Wendum D Corpechot C	1999	Am-J-Patbol1999，155，4：	1
13	Notch3 mutations in CADA- SIL, a hereditary adult - onset condition causing stroke and dementia 显示文摘	Joutel A Corpechot C Ducros A	1996	Nature1996，383，6602：	1
14	Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia显示文摘	Joutel A Corpechot C Ducros A	1996	Nature1996，383，6602：	1
15	The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis显示文摘	Corpechot C Carrat F Bonnand AM		0，，06：	1
16	Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis 显示文摘	Corpechot C Barbu V Wendum D	2002	Hepatology2002，35，5：	1
17	Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis显示文摘	Poupon R Chazouilleres O Corpechot C	2006	Hepatol2006，44，：	1
18	Noninvasive elastography - based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis 显示文摘	Corpechot C Carrat F Poujol-Robert A	2012	Hepatology2012，5611，：	1
19	Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients 显示文摘	Joutel A Vahedi K Corpechot C	1997	Lancet1997，350，9090：	1
20	Geotherapeutics of primary biliary cirrhosis: bright and sunny around the Mediterranean but still cloudy and foggy in the United Kingdom显示文摘	Corpechot C Poupon R	2007	Hepatology2007，46，4：	1

返回顶部每页显示：

共10页首页上一页第1页下一页末页 /10 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示